Glaser et al., 1988), and no differences have been reported in circulating PP between obese subjects and lean individuals (Jorde and Burhol, 1984)
There is an urgent need for studies to clarify how to maintain weight loss over the long term in those who choose the drug management route, and to identify how to help people engage and be more successful with the behavioural weight management programmes currently available, including the NHS Digital Weight Management Programme and the NHS Weight Loss Plan
Medication Conflicts Because cagrilintide slows gastric emptying, it can change how oral medications are absorbed
Baseline thyroid assessment before initiating GLP-1 therapy is clinically prudent for patients with Hashimoto's disease and should include thyroid-stimulating hormone (TSH) and free thyroxine (T4) levels to ensure the patient's hypothyroidism is adequately controlled on their current levothyroxine dose
However, prolonged exposure to GLP-1RAs can lead to tachyphylaxis, reducing their effect on gastric emptying over time
In these cases, a provider might add a low dose of phentermine for a short period to re-jumpstart the metabolism